Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A double-blind, randomized, placebo-controlled phase 2 trial evaluating the selective dihydroorotate dehydrogenase inhibitor vidofludimus calcium in relapsing-remitting multiple sclerosis.
Ann Clin Transl Neurol. 2022 Jul;9(7):977-987. doi: 10.1002/acn3.51574. Epub 2022 Jun 14.
Ann Clin Transl Neurol. 2022.
PMID: 35698927
Free PMC article.
Clinical Trial.
Hydroxychloroquine for prophylaxis and treatment of COVID-19 in health-care workers.
Simova I, Vekov T, Krasnaliev J, Kornovski V, Bozhinov P.
Simova I, et al.
New Microbes New Infect. 2020 Nov;38:100813. doi: 10.1016/j.nmni.2020.100813. Epub 2020 Nov 12.
New Microbes New Infect. 2020.
PMID: 33204427
Free PMC article.
No abstract available.
Item in Clipboard
Safety and Dose-Response of Vidofludimus Calcium in Relapsing Multiple Sclerosis: Extended Results of a Placebo-Controlled Phase 2 Trial.
Fox RJ, Wiendl H, Wolf C, De Stefano N, Sellner J, Gryb V, Rejdak K, Bozhinov PS, Vitt D, Kohlhof H, Slizgi J, Ondrus M, Sciacca V, Muehler AR; EMPhASIS investigators.
Fox RJ, et al. Among authors: bozhinov ps.
Neurol Neuroimmunol Neuroinflamm. 2024 May;11(3):e200208. doi: 10.1212/NXI.0000000000200208. Epub 2024 Apr 25.
Neurol Neuroimmunol Neuroinflamm. 2024.
PMID: 38662979
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite